Glaukos (NYSE:GKOS) announced today that it entered into exchange agreements to repurchase approximately $230 million. The company entered into separate, privately negotiated exchange agreements with certain holders of 2.75% convertible senior notes due 2027. Pursuant to these agreements, the company agreed to repurchase $230 million of existing convertible notes for aggregate consideration of shares of […]
Vision
Bausch + Lomb wins Health Canada nod for enVista Envy full visual range intraocular lens
Bausch + Lomb today announced it received Health Canada approval for its enVista Envy full visual range intraocular lens. The Health Canada nod is the first regulatory approval of the new lens that offers a full range of vision with dysphotopsia tolerance on the enVista IOL platform. “enVista Envy is the next step in the […]
Sight Sciences to earn $34M from Alcon patent infringement suit
Sight Sciences (Nasdaq:SGHT) announced today that it received a jury trial verdict awarding it $34 million from a patent infringement case against Alcon. The company filed the case on Sept. 16, 2021, against Alcon, Alcon Vision, Alcon Research and Ivantis (collectively Alcon) in the U.S. Menlo Park, California-based Sight Sciences asserted that Alcon’s sale of […]
BCI maker Science acquires retinal implant from Pixium Vision
Brain-computer interface developer Science Corporation announced today that it acquired the IP and related assets for the Pixium Vision Prima implant. Neuralink co-founder Max Hodak founded Science, which unveiled its Science Eye brain-computer platform in 2022. The Science Eye is a visual prosthesis. It targets retinitis pigmentosa (RP) and dry age-related macular degeneration (AMD), two […]
10 new, innovative medical devices to watch for in 2024
By Senior Editor Danielle Kirsh and Associate Editor Sean Whooley Significant medical device launches are coming in 2024. Think pulsed field ablation, diabetes treatment tech, surgical robotics and more. Pulsed field ablation news took over at the end of 2023 and the start of 2024, with Medtronic and Boston Scientific garnering significant regulatory approvals. Surgical […]
Carl Zeiss completes $1B ophthalmic company buy
Carl Zeiss Meditec announced today that it completed its $1 billion acquisition of D.O.R.C. (Dutch Ophthalmic Research Center). In December 2023, Carl Zeiss entered into an agreement to acquire 100% of the shares in D.O.R.C. The Germany-based company acquired DORC from the France-based investment firm Eurazeo, valuing the deal at €985 million (approximately $1.07 billion). […]
Fast Company names 10 medtech companies as most innovative of 2024
Fast Company recently named 10 medical device companies as some of the most innovative companies of 2024. Each year, Fast Company releases its list of the world’s most innovative companies. The list covers 58 industries and sectors, ranging from advertising to video. Companies on the “Most Innovative” list apply to be included, and then Fast […]
Johnson & Johnson launches new intraocular lens in EMEA
Johnson & Johnson MedTech announced that its Vision unit made the Tecnis PureSee lens available in the EMEA region. Tecnis PureSee is a purely refractive, presbyopia-correcting intraocular lens (IOL). It features a proprietary design aimed at delivering uninterrupted, high-quality vision. Johnson & Johnson says it offers high best-in-category contrast and low-light performance compared to a […]
Zeiss, Topcon settle trade secret theft lawsuit
Carl Zeiss Meditec said today that it reached a favorable resolution to settle a lawsuit against Topcon subsidiaries regarding trade secrets. The company’s suit against Topcon’s U.S.-based subsidiaries had been pending in the U.S. federal court for the Northern District of California. Zeiss said the settlement reinforces the protection of its trade secrets and “restores […]
Sight Sciences closes $65M credit facility
Sight Sciences (Nasdaq:SGHT) announced that it closed a senior secured credit facility worth up to $65 million. The credit facility with Hercules Capital includes the immediate draw of $35 million. Menlo Park, California–based Sight Sciences used the proceeds to pay off the principal amount of debt to its previous secured lender. In addition to the […]
FDA approves Zeiss software that treats nearsightedness
Zeiss Medical Technology announced that the FDA approved the VisuMax 800 with Smile Pro software. The Carl Zeiss Meditec unit designed the software to treat nearsightedness, with or without astigmatism. Its latest generation of femtosecond lasers enters the U.S. market with more than 8 million eyes already treated with Smile software. “The increasing global adoption […]
